| Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars SA Berkowitz, JR Engen, JR Mazzeo, GB Jones Nature Reviews Drug Discovery 11 (7), 527-540, 2012 | 596 | 2012 |
| Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity LC Kourtis, OB Regele, JM Wright, GB Jones NPJ digital medicine 2 (1), 9, 2019 | 289 | 2019 |
| Surface functionalization of gold nanoparticles using hetero-bifunctional poly (ethylene glycol) spacer for intracellular tracking and delivery D Shenoy, W Fu, J Li, C Crasto, G Jones, C DiMarzio, S Sridhar, M Amiji International journal of nanomedicine 1 (1), 51-57, 2006 | 276 | 2006 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 232 | 2022 |
| Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer WK Oh, PW Kantoff, V Weinberg, G Jones, BI Rini, MK Derynck, R Bok, ... Journal of Clinical Oncology 22 (18), 3705-3712, 2004 | 164 | 2004 |
| A systematic genomewide linkage study in 353 sib pairs with schizophrenia NM Williams, N Norton, H Williams, B Ekholm, ML Hamshere, Y Lindblom, ... The American journal of human genetics 73 (6), 1355-1367, 2003 | 144 | 2003 |
| π stacking effects in asymmetric synthesis GB Jones, BJ Chapman Synthesis 1995 (05), 475-497, 1995 | 129 | 1995 |
| Preoperative risk factors for conversion from laparoscopic to open cholecystectomy: a validated risk score derived from a prospective UK database of 8820 patients RP Sutcliffe, M Hollyman, J Hodson, G Bonney, RS Vohra, EA Griffiths, ... Hpb 18 (11), 922-928, 2016 | 125 | 2016 |
| Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo KJ Starkey, A Janezic, G Jones, N Jordan, G Baker, M Ludgate Journal of Molecular Endocrinology 30 (3), 369-380, 2003 | 122 | 2003 |
| A2A adenosine receptor gene deletion or synthetic A2A antagonist liberate tumor-reactive CD8+ T cells from tumor-induced immunosuppression J Kjaergaard, S Hatfield, G Jones, A Ohta, M Sitkovsky The Journal of Immunology 201 (2), 782-791, 2018 | 120 | 2018 |
| Annulation Strategies for Benzo[b]fluorene Synthesis: Efficient Routes to the Kinafluorenone and WS-5995 Antibiotics G Qabaja, GB Jones The Journal of Organic Chemistry 65 (21), 7187-7194, 2000 | 114 | 2000 |
| Population‐based cohort study of outcomes following cholecystectomy for benign gallbladder diseases CholeS Study Group, West Midlands Research Collaborative, RS Vohra, ... British Journal of Surgery 103 (12), 1704-1715, 2016 | 113 | 2016 |
| Designed enediyne antitumor agents GB Jones, FS Fouad Current pharmaceutical design 8 (27), 2415-2440, 2002 | 110 | 2002 |
| Electronic control of the Bergman cyclization: the remarkable role of vinyl substitution GB Jones, PM Warner Journal of the American Chemical Society 123 (10), 2134-2145, 2001 | 109 | 2001 |
| Tetracycline compounds having target therapeutic activities SB Levy, M Draper, ML Nelson, G Jones | 106 | 2003 |
| π Shielding in organic synthesis GB Jones Tetrahedron 57 (38), 7999-8016, 2001 | 105 | 2001 |
| Reductive cleavage of tert-butyldimethylsilyl ethers by diisobutylaluminum hydride EJ Corey, GB Jones The Journal of Organic Chemistry 57 (3), 1028-1029, 1992 | 95 | 1992 |
| Methods of using substituted tetracycline compounds to modulate RNA SB Levy, M Draper, ML Nelson, G Jones US Patent 8,173,624, 2012 | 93 | 2012 |
| Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study DJ Cook, G Rocker, M Meade, G Guyatt, W Geerts, D Anderson, Y Skrobik, ... Journal of critical care 20 (4), 364-372, 2005 | 91 | 2005 |
| Catalytic asymmetric induction part 2. Chiral tricarbonyl (η6 arene) chromium (0) complexes as enantioselective catalysts GB Jones, SB Heaton Tetrahedron: Asymmetry 4 (2), 261-272, 1993 | 91 | 1993 |
Justin M. WrightGlobal Head Connected Health, NovartisVerified email at novartis.com
